Jovan-Embiricos Morana
Insider CIK 1575745 · RDUS Director, 10% owner · TCRR Director, 10% owner · ALVR Director, 10% owner · CGEM Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 9,000 | — | $0 | 9,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2025-04-10 | 2025-04-11 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2024-06-06 | 2024-06-07 | 35,000 | — | $0 | 100,197 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2023-05-11 | 2023-05-12 | 35,000 | — | $0 | 65,197 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-08-04 | 2022-08-04 | 25,989 | $14.31 | $371.9K | 1,255,963 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-08-03 | 2022-08-04 | 19,129 | $14.24 | $272.4K | 1,281,952 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-08-02 | 2022-08-04 | 4,792 | $14.10 | $67.6K | 1,301,081 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 684,622 | $4.61 | $3.16M | 2,059,884 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 1,626,898 | $4.61 | $7.50M | 2,038,583 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 1,393,874 | $4.61 | $6.43M | 4,193,874 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 867,678 | $4.61 | $4.00M | 867,678 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 3,253,796 | $4.61 | $15.00M | 16,674,766 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 325,379 | $4.61 | $1.50M | 668,072 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise deriv | 2022-06-24 | 2022-06-28 | 104,845 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise deriv | 2022-06-24 | 2022-06-28 | 35,529 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise | 2022-06-24 | 2022-06-28 | 35,529 | $4.30 | $152.8K | 252,881 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | M Exercise | 2022-06-24 | 2022-06-28 | 104,845 | $4.30 | $450.8K | 217,352 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | F Tax w/h | 2022-06-24 | 2022-06-28 | 45,078 | $13.39 | $603.6K | 207,803 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-06-23 | 2022-06-23 | 29,631 | $13.00 | $385.2K | 537,392 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-06-22 | 2022-06-23 | 49,953 | $12.70 | $634.4K | 567,023 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-06-21 | 2022-06-23 | 22,319 | $12.77 | $285.0K | 616,976 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 27,500 | — | $0 | 27,500 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-05-16 | 2022-05-16 | 35,158 | $11.23 | $394.8K | 1,305,873 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-05-13 | 2022-05-16 | 34,189 | $10.48 | $358.3K | 1,341,031 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-05-13 | 2022-05-16 | 85,319 | $9.96 | $849.8K | 1,375,220 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2022-05-12 | 2022-05-16 | 264,072 | $9.25 | $2.44M | 1,460,539 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | J Other | 2022-01-11 | 2022-01-13 | 1,187,734 | — | $0 | 1,724,611 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-11-10 | 2021-11-15 | 120 | $24.77 | $3.0K | 342,693 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-11-10 | 2021-11-15 | 680 | $24.77 | $16.8K | 1,375,262 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-11-09 | 2021-11-09 | 3,243 | $24.79 | $80.4K | 1,375,942 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-11-09 | 2021-11-09 | 572 | $24.79 | $14.2K | 342,813 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-11-05 | 2021-11-09 | 7,124 | $24.80 | $176.7K | 1,379,185 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-11-05 | 2021-11-09 | 1,257 | $24.80 | $31.2K | 343,385 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-27 | 2021-10-29 | 1,870 | $24.78 | $46.3K | 1,386,309 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-27 | 2021-10-29 | 330 | $24.78 | $8.2K | 344,642 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-25 | 2021-10-25 | 6,604 | $24.82 | $163.9K | 1,388,179 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-25 | 2021-10-25 | 1,165 | $24.82 | $28.9K | 344,972 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-22 | 2021-10-25 | 4,864 | $24.77 | $120.5K | 1,394,783 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-22 | 2021-10-25 | 859 | $24.77 | $21.3K | 346,137 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-21 | 2021-10-25 | 85 | $24.75 | $2.1K | 1,399,647 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2021-10-21 | 2021-10-25 | 15 | $24.75 | $371 | 346,996 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | A Award deriv | 2021-09-16 | 2022-03-25 | 7,800 | — | $0 | 7,800 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2021-05-25 | 2021-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 503,988 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 1,282,051 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 1,007,977 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 503,988 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 1,511,966 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 8,000,000 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 20,500,000 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 3,205,128 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 4,500,000 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | P Buy | 2021-01-12 | 2021-01-14 | 95,238 | $21.00 | $2.00M | 622,175 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 214,798 | — | $0 | 214,798 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 71,599 | — | $0 | 71,599 | SEC↗ |
| CGEM Cullinan Management, Inc. | P Buy | 2021-01-12 | 2021-01-14 | 104,762 | $21.00 | $2.20M | 104,762 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 143,198 | — | $0 | 325,333 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 71,599 | — | $0 | 526,937 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 182,135 | — | $0 | 182,135 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 455,338 | — | $0 | 455,338 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 639,295 | — | $0 | 639,295 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 2,912,345 | — | $0 | 2,912,345 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 1,136,525 | — | $0 | 1,136,525 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-06 | 613,496 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-06 | 368,098 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-06 | 2,085,889 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-06 | 20,000,000 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | P Buy | 2020-08-03 | 2020-08-06 | 100,000 | $17.00 | $1.70M | 347,011 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-06 | 247,011 | — | $0 | 247,011 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-06 | 13,420,970 | — | $0 | 13,420,970 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-06 | 411,685 | — | $0 | 411,685 | SEC↗ |
| ALVR Allovir, Inc. | P Buy | 2020-08-03 | 2020-08-06 | 2,800,000 | $17.00 | $47.60M | 2,800,000 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-06 | 1,399,732 | — | $0 | 1,399,732 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2020-07-29 | 2020-07-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2019-12-20 | 2019-12-20 | 13,847 | — | $0 | 161,024 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2019-12-20 | 2019-12-20 | 586,153 | — | $0 | 713,723 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-19 | 2019-12-20 | 6,642 | $16.47 | $109.4K | 82,575 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-19 | 2019-12-20 | 35,323 | $16.47 | $581.8K | 155,986 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-18 | 2019-12-20 | 2,433 | $17.01 | $41.4K | 191,309 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-18 | 2019-12-20 | 458 | $17.01 | $7.8K | 89,217 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-11 | 2019-12-11 | 4,153 | $17.65 | $73.3K | 1,299,876 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-11 | 2019-12-11 | 1,054 | $17.65 | $18.6K | 330,238 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-11 | 2019-12-11 | 1,381 | $17.65 | $24.4K | 432,319 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-11 | 2019-12-11 | 1,155 | $17.65 | $20.4K | 361,665 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-10 | 2019-12-11 | 30,475 | $17.62 | $537.0K | 1,304,029 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-10 | 2019-12-11 | 7,741 | $17.62 | $136.4K | 331,292 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-10 | 2019-12-11 | 10,135 | $17.62 | $178.6K | 433,700 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-10 | 2019-12-11 | 8,479 | $17.62 | $149.4K | 362,820 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-09 | 2019-12-11 | 75,067 | $17.65 | $1.32M | 1,334,504 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-09 | 2019-12-11 | 19,070 | $17.65 | $336.6K | 339,033 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-09 | 2019-12-11 | 24,966 | $17.65 | $440.6K | 443,835 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-12-09 | 2019-12-11 | 20,886 | $17.65 | $368.6K | 371,299 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-10-22 | 2019-10-24 | 580 | $15.16 | $8.8K | 392,185 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-10-22 | 2019-10-24 | 693 | $15.16 | $10.5K | 392,185 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-10-22 | 2019-10-24 | 530 | $15.16 | $8.0K | 358,103 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-10-22 | 2019-10-24 | 2,085 | $15.16 | $31.6K | 1,409,571 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-23 | 2019-09-24 | 5,516 | $17.31 | $95.5K | 1,411,656 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-23 | 2019-09-24 | 683 | $17.31 | $11.8K | 174,871 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-23 | 2019-09-24 | 351 | $17.31 | $6.1K | 89,675 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-23 | 2019-09-24 | 1,835 | $17.31 | $31.8K | 469,464 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-23 | 2019-09-24 | 1,401 | $17.31 | $24.3K | 358,633 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-23 | 2019-09-24 | 1,535 | $17.31 | $26.6K | 392,765 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-20 | 2019-09-24 | 50,134 | $17.94 | $899.4K | 360,034 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-20 | 2019-09-24 | 24,446 | $17.94 | $438.6K | 175,554 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-20 | 2019-09-24 | 65,633 | $17.94 | $1.18M | 471,299 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-20 | 2019-09-24 | 197,343 | $17.94 | $3.54M | 1,417,172 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-20 | 2019-09-24 | 12,537 | $17.94 | $224.9K | 90,026 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-20 | 2019-09-24 | 54,907 | $17.94 | $985.0K | 394,300 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-04 | 2019-09-05 | 12,214 | $17.55 | $214.4K | 102,563 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-09-03 | 2019-09-05 | 10,559 | $17.01 | $179.6K | 114,777 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-08-29 | 2019-09-05 | 3,700 | $17.01 | $62.9K | 125,336 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-08-28 | 2019-09-05 | 6,700 | $17.01 | $114.0K | 129,036 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-08-27 | 2019-09-05 | 1,200 | $17.01 | $20.4K | 135,736 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-08-26 | 2019-09-05 | 29,128 | $17.01 | $495.5K | 136,936 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-08-23 | 2019-09-05 | 3 | $17.00 | $51 | 166,064 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-08-22 | 2019-09-05 | 100 | $17.03 | $1.7K | 166,067 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2019-08-21 | 2019-09-05 | 500 | $17.00 | $8.5K | 166,167 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 2,500,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 10,000,001 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 1,200,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 2,540,500 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 1,750,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 193,742 | — | $0 | 193,742 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | P Buy | 2019-02-19 | 2019-02-21 | 166,667 | $15.00 | $2.50M | 449,207 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | P Buy | 2019-02-19 | 2019-02-21 | 133,333 | $15.00 | $2.00M | 536,962 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 1,614,515 | — | $0 | 1,614,515 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | P Buy | 2019-02-19 | 2019-02-21 | 166,667 | $15.00 | $2.50M | 166,667 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 410,168 | — | $0 | 410,168 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 282,540 | — | $0 | 282,540 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 403,629 | — | $0 | 403,629 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | P Buy | 2019-02-19 | 2019-02-21 | 200,000 | $15.00 | $3.00M | 200,000 | SEC↗ |
| RDUS Radius Health, Inc. | J Other deriv | 2015-01-08 | 2015-01-12 | 89,261 | — | $0 | 267,786 | SEC↗ |
| RDUS Radius Health, Inc. | J Other deriv | 2015-01-08 | 2015-01-20 | 89,261 | — | $0 | 267,786 | SEC↗ |
| RDUS Radius Health, Inc. | J Other | 2015-01-08 | 2015-01-12 | 389,331 | — | $0 | 1,167,997 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2014-12-17 | 2014-12-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RDUS Radius Health, Inc. | J Other | 2014-07-15 | 2015-01-15 | 335,820 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | J Other | 2014-07-10 | 2015-01-15 | 251,680 | — | $0 | 335,820 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-11 | 2014-06-13 | 227,938 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-11 | 2014-06-13 | 110,713 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-11 | 2014-06-13 | 1,794,983 | — | $0 | 1,794,983 | SEC↗ |
| RDUS Radius Health, Inc. | P Buy | 2014-06-11 | 2014-06-13 | 587,500 | $8.00 | $4.70M | 587,500 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-11 | 2014-06-13 | 871,851 | — | $0 | 871,851 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 325,627 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 1,557,328 | — | $0 | 1,557,328 | SEC↗ |
| NONE Radius Health, Inc. | A Award deriv | 2014-02-14 | 2014-02-19 | 569,845 | — | $0 | 569,845 | SEC↗ |
| NONE Radius Health, Inc. | A Award deriv | 2014-02-14 | 2014-02-19 | 276,783 | — | $0 | 276,783 | SEC↗ |
| NONE Radius Health, Inc. | A Award deriv | 2014-02-14 | 2014-02-19 | 110,713 | $61.42 | $6.80M | 110,713 | SEC↗ |
| NONE Radius Health, Inc. | A Award deriv | 2014-02-14 | 2014-02-19 | 227,938 | $61.42 | $14.00M | 227,938 | SEC↗ |